6 juin 2017 Toulouse (France)
Evolution of Bacterial Chaperones Towards the Inhibition of Alzheimer's Amyloid Beta Peptide Aggregation
Sara Maria Ayala Mariscal  2, 1@  , Ambre Sala  1@  , Samuel Tranier  3@  , Lionel Mourey, Christelle Hureau  4@  , Peter Faller  5@  , Pierre Genevaux  1@  
2 : Laboratoire de Chimie de Coordination  (LCC)
Université Paul Sabatier - Toulouse III
1 : Laboratoire de Microbiologie et Génétique Moléculaires  (LMGM)
Université Paul Sabatier - Toulouse III
3 : Institut de pharmacologie et de biologie structurale  (IPBS)  -  Site web
Université Paul Sabatier - Toulouse 3, Centre National de la Recherche Scientifique : UMR5089
205 Route de Narbonne 31077 TOULOUSE CEDEX 4 -  France
4 : Laboratoire de chimie de coordination  (LCC)  -  Site web
Centre National de la Recherche Scientifique : UPR8241
205 Route de Narbonne 31077 TOULOUSE CEDEX 4 -  France
5 : Institut de Chimie de Strasbourg
université de Strasbourg

Universally conserved molecular chaperone machines assist de novo protein folding and efficiently rescue cellular proteins from cytotoxic aggregation induced by stress, aging or certain mutations. Alzheimer's disease is the most frequent type of dementia and to date there is no early diagnosis technic or curative treatment available. Alzheimer is directly linked to protein aggregation and it has been proposed that the use of molecular chaperones might lead to promising new therapeutic approaches. In this work, we have looked upon a bacterial chaperone with an unusually robust holdase activity, as a promising modulator of Alzheimer's related Amyloid Beta (AB) peptide aggregation.  


Personnes connectées : 1